Since impaired endothelium-dependent NO signalling is a central trigger of a wide range of cardiovascular disease (from hypertensive, to diabetic, to atherosclerotic), downregulation of Cygb or its NOD function, in order to enhance vascular NO levels and restore protective NO signalling, could provide a much needed remedy. The gene discussed is CYGB; the disease is cardiovascular disorder.